Discontinued — last reported Q3 '25

Operating

Impairment Charges

Danaher Impairment Charges decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $15.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2014
Last reportedQ3 2025

How to read this metric

An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.

Detailed definition

These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...

Peer comparison

Often seen during restructuring or economic downturns across industrial sectors.

Metric ID: impairment_charges_cf

Historical Data

14 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$35.00M$0.00$0.00$222.00M$43.00M$15.00M$432.00M$101.00M$14.00M$0.00
QoQ Change-100.0%-80.6%-65.1%>999%-76.6%-86.1%-100.0%
YoY Change+22.9%-54.5%-67.4%-100.0%
Range$0.00$432.00M
Avg YoY Growth-49.8%
Median YoY Growth-61.0%
Current Streak3 quarters decline

Business Segments

View all
SegmentQ2 '23Q3 '23Q4 '23Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25
Life Sciences$0.00$0.00$0.00$0.00$432.00M$14.00M
Biotechnology$13.50M$13.50M$13.50M$0.00$15.00M$0.00$86.00M
Biotechnology and Diagnostics$19.25M$19.25M$19.25M
Diagnostics$5.75M$5.75M$5.75M$0.00
Total$35.00M$222.00M$15.00M$432.00M$101.00M$14.00M

Life Sciences, Biotechnology and Diagnostics Segment is derived from annual filings.

Biotechnology, Biotechnology and Diagnostics, Diagnostics, Life Sciences were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Danaher's impairment charges?
Danaher (DHR) reported impairment charges of $0.00 in Q1 2026.
How has Danaher's impairment charges changed year-over-year?
Danaher's impairment charges decreased by 100.0% year-over-year, from $15.00M to $0.00.
What does impairment charges mean?
A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.